Literature DB >> 28125848

[FIMPsy - Questionnaire for the Assessment of Medical and non Medical Resource Utilisation in Mental Disorders: Development and Application].

Helen Grupp1, Hans-Helmut König1, Steffi Riedel-Heller2, Alexander Konnopka1.   

Abstract

OBJECTIVE: In Germany, patients with mental disorders can benefit from many medical and non-medical services. However, assessing the consumption of these services is difficult. We developed the questionnaire FIMPsy that can be used to assess health care consumption in patients with mental disorders and thereby facilitate economic evaluations.
METHODS: We identified relevant medical and non-medical services for patients with mental disorders and included frequently consumed services in the questionnaire.
RESULTS: FIMPsy can be utilized to assess the consumption of the following services in the preceding six months retrospectively: informal care, psychiatric counselling, psychosocial care, assisted living and occupational integration. Furthermore, FIMPsy assesses contacts with outpatient and inpatient medical providers as well as the intake of medication.
CONCLUSION: FIMPsy covers many services for patients with mental disorders. It can be applied in economic evaluations and thus facilitate and standardize their implementation. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh：

Year:  2017        PMID： 28125848     DOI： 10.1055/s-0042-118033

Source DB:  PubMed          Journal:  Psychiatr Prax        ISSN： 0303-4259


  10 in total

1.  Excess costs of mental disorders by level of severity.

Authors:  Hannah König; Hans-Helmut König; Jürgen Gallinat; Martin Lambert; Anne Karow; Judith Peth; Holger Schulz; Alexander Konnopka
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2022-05-31       Impact factor: 4.328

2.  Specialized post-inpatient psychotherapy for sustained recovery in anorexia nervosa via videoconference - study protocol of the randomized controlled SUSTAIN trial.

Authors:  Katrin Elisabeth Giel; Peter Martus; Kathrin Schag; Stephan Herpertz; Tobias Hofmann; Antonius Schneider; Martin Teufel; Ulrich Voderholzer; Jörn von Wietersheim; Beate Wild; Almut Zeeck; Wolfgang Bethge; Ulrike Schmidt; Stephan Zipfel; Florian Junne
Journal:  J Eat Disord       Date:  2021-05-19

3.  Mental health specialist video consultations for patients with depression or anxiety disorders in primary care: protocol for a randomised controlled feasibility trial.

Authors:  Justus Tönnies; Mechthild Hartmann; Michel Wensing; Joachim Szecsenyi; Andrea Icks; Hans-Christoph Friederich; Markus W Haun
Journal:  BMJ Open       Date:  2019-09-04       Impact factor: 2.692

4.  Mental Health Specialist Video Consultations Versus Treatment-as-Usual for Patients With Depression or Anxiety Disorders in Primary Care: Randomized Controlled Feasibility Trial.

Authors:  Justus Tönnies; Mechthild Hartmann; Michel Wensing; Joachim Szecsenyi; Frank Peters-Klimm; Regina Brinster; Dorothea Weber; Markus Vomhof; Andrea Icks; Hans-Christoph Friederich; Markus W Haun
Journal:  JMIR Ment Health       Date:  2021-03-12

5.  Mental health specialist video consultations versus treatment as usual in patients with depression or anxiety disorders in primary care: study protocol for an individually randomised superiority trial (the PROVIDE-C trial).

Authors:  Markus W Haun; Justus Tönnies; Regina Krisam; Dorothea Kronsteiner; Michel Wensing; Joachim Szecsenyi; Markus Vomhof; Andrea Icks; Beate Wild; Mechthild Hartmann; Hans-Christoph Friederich
Journal:  Trials       Date:  2021-05-05       Impact factor: 2.279

6.  Mental health specialist video consultations for patients with somatic symptom disorder in primary care: protocol for a randomised feasibility trial (the VISION trial).

Authors:  Markus W Haun; Justus Tönnies; Leike Graue; Mechthild Hartmann; Michel Wensing; Joachim Szecsenyi; Beate Wild; Hans-Christoph Friederich
Journal:  BMJ Open       Date:  2022-04-11       Impact factor: 2.692

7.  Mixed-methods investigation of barriers and needs in mental healthcare of adults with autism and recommendations for future care (BarrierfreeASD): study protocol.

Authors:  Nicole David; Sophia Dückert; Petia Gewohn; Hannah König; Pascal Rahlff; Frank Erik; Kai Vogeley; Daniel Schöttle; Alexander Konnopka; Holger Schulz; Judith Peth
Journal:  BMJ Open       Date:  2022-08-23       Impact factor: 3.006

8.  Increasing the effectiveness of psychotherapy in routine care through blended therapy with transdiagnostic online modules (PsyTOM): study protocol for a randomized controlled trial.

Authors:  Johanna Boettcher; Christine Knaevelsrud; Carmen Schaeuffele; Manuel Heinrich; Solveig Behr; Friederike Fenski; Leona Hammelrath; Pavle Zagorscak; Alessa Jansen; Steffi Pohl
Journal:  Trials       Date:  2022-09-30       Impact factor: 2.728

9.  Study protocol for a randomised controlled trial evaluating an evidence-based, stepped and coordinated care service model for mental disorders (RECOVER).

Authors:  Martin Lambert; Anne Karow; Jürgen Gallinat; Daniel Lüdecke; Vivien Kraft; Anja Rohenkohl; Romy Schröter; Constanze Finter; Anna-Katharina Siem; Lisa Tlach; Nathalie Werkle; Susann Bargel; Gunda Ohm; Martin Hoff; Helmut Peter; Martin Scherer; Claudia Mews; Susanne Pruskil; Johannes Lüke; Martin Härter; Jörg Dirmaier; Michael Schulte-Markwort; Bernd Löwe; Peer Briken; Heike Peper; Michael Schweiger; Mike Mösko; Thomas Bock; Martin Wittzack; Hans-Jochim Meyer; Arno Deister; Rolf Michels; Stephanie Herr; Alexander Konnopka; Hannah König; Karl Wegscheider; Anne Daubmann; Antonia Zapf; Judith Peth; Hans-Helmut König; Holger Schulz
Journal:  BMJ Open       Date:  2020-05-04       Impact factor: 2.692

10.  In Search for Comparability: The PECUNIA Reference Unit Costs for Health and Social Care Services in Europe.

Authors:  Susanne Mayer; Michael Berger; Alexander Konnopka; Valentin Brodszky; Silvia M A A Evers; Leona Hakkaart-van Roijen; Mencia R Guitérrez-Colosia; Luis Salvador-Carulla; A-La Park; William Hollingworth; Lidia García-Pérez; Judit Simon
Journal:  Int J Environ Res Public Health       Date:  2022-03-16       Impact factor: 3.390
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.